日本の不妊・妊娠迅速キット市場：製品別、検査タイプ別、流通チャネル別、地域別、機会、予測、2018年～2032年

日本の不妊・妊娠迅速検査キットの市場規模は、2025年～2032年の予測期間中に6.00％のCAGRで拡大し、2024年の1億1,623万米ドルから2032年には1億8,525万米ドルに成長すると予測されています。同市場の成長の背景には、ライフスタイルの進化に伴い国内で不妊症の症例が増加し、その結果、比較的簡便に使用できる家庭用の迅速検査ソリューションに対する需要が高まっていることが挙げられます。さらに、リプロダクティブ・ヘルスと不妊に関する意識の高まり、テクノロジーに精通した人口と先進的なヘルスケア・セクターの存在も、市場に有利な成長機会をもたらしています。一方、オンラインやオフラインのさまざまな小売チャネルでこれらのキットを簡単に入手できることも、ユーザーの利便性とアクセシビリティを高め、市場の拡大をさらに後押ししています。

さらに、働く女性の数が増加していることも、子作りの遅れに寄与しており、不妊治療キットや生殖能力を追跡するためのその他のソリューションへの依存度を高めています。一般の人々は、こうしたツールが提供するプライバシーや、迅速な結果の入手が可能なことから、こうしたキットを好みます。国際通貨基金が2023年11月に発表した統計によると、女性の労働力率は2012年の63％から2022年には74％に上昇しました。

さらに、ヘルスケア・サービスへのアクセスを改善し、リプロダクティブ・ヘルスを促進するための政府の取り組みが増加していることも、日本市場の進化に重要な役割を果たすと予想されます。流通網を拡大するためにヘルスケアプロバイダーとメーカー間の協力が増加していることで、キットがより多くの人々に確実に行き渡るようになっています。さらに、日本ではユーザーフレンドリーで効果的な診断ツールへの嗜好が高まっていることも、市場の拡大にプラスの影響を与えています。

当レポートでは、日本の不妊・妊娠迅速キット市場について調査し、市場の概要とともに、製品別、検査タイプ別、流通チャネル別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 日本の不妊・妊娠迅速キット市場の見通し、2018年～2032年

• 市場規模の分析と予測
• 市場シェア分析と予測
• マーケットマップ分析、2024年
  • 製品別
  • 検査タイプ別
  • 流通チャネル別
  • 地域別

第5章 需要供給分析

第6章 バリューチェーン分析

第7章 ポーターのファイブフォース分析

第8章 PESTLE分析

第9章 価格分析

第10章 市場力学

第11章 市場の動向と発展

第12章 規制枠組みとイノベーション

第13章 特許の情勢

第14章 ケーススタディ

第15章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要企業トップ10の情勢
  • Alere Inc.
  • Quidel Corporation
  • Prestige Brands Holdings, Inc.
  • Church & Dwight Co., Inc.
  • bioMerieux SA
  • Geratherm Medical AG
  • Abbott Laboratories
  • Procter & Gamble Co.
  • DCC Plc.
  • MIZUHO MEDY Co., Ltd.

第16章 戦略的提言

第17章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Fertility and Pregnancy Rapid Kits Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. Japan Fertility and Pregnancy Rapid Kits Market Share (%), By Product, FY2018-FY2032F
• Figure 3. Japan Fertility and Pregnancy Rapid Kits Market Share (%), By Test Type, FY2018-FY2032F
• Figure 4. Japan Fertility and Pregnancy Rapid Kits Market Share (%), By Distribution Channel, FY2018-FY2032F
• Figure 5. Japan Fertility and Pregnancy Rapid Kits Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 7. By Test Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By Distribution Channel Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024

Japan fertility and pregnancy rapid kits market is projected to witness a CAGR of 6.00% during the forecast period FY2025-FY2032, growing from USD 116.23 million in FY2024 to USD 185.25 million in FY2032. The growth of the market can be attributed to the rising cases of infertility in the country due to evolving lifestyles, resulting in an increased demand for at-home, rapid testing solutions, that are relatively convenient to use. Additionally, the rising awareness about reproductive health and fertility, along with the presence of a tech-savvy population and an advanced healthcare sector, are also providing lucrative growth opportunities for the market. Meanwhile, the easy availability of these kits across different online and offline retail channels also enhances user convenience and accessibility, further propelling the market's expansion.

Moreover, the rising number of working women is also contributing to delayed parenthood and increasing the reliance on fertility kits and other solutions for tracking fertility. The general population prefers such kits due to the privacy offered by these tools and the availability of rapid results. According to statistics released by the International Monetary Fund in November 2023, female participation in the labor force rose from 63% in 2012 to 74% in 2022.

Additionally, increasing government efforts to improve access to healthcare services and promote reproductive health is also expected to play a significant role in Japan's market evolution. Increasing collaborations between healthcare providers and manufacturers to expand their distribution networks is allowing them to ensure that their kits reach a wider population base. Moreover, the growing preference for user-friendly and effective diagnostic tools in the country also positively influences the market's expansion.

Rising Cases of Infertility Boost Market Expansion

Increasing cases of infertility in Japan is one of the major drivers of the country's fertility and pregnancy rapid kits market. As per the estimates of an article published in the Journal of Occupational Health in April 2024, 1 in 4.4 couples in Japan are undergoing infertility testing or treatments. As more and more couples face difficulties in conceiving, they rely on fertility monitoring solutions, including fertility rapid kits, to assess their fertility status. Additionally, the growing preference for self-monitoring and discreet health solutions is also propelling the market's demand. Such kits allow couples to privately monitor their reproductive health and seek medical help in cases of fertility decline.

Supportive Government Initiatives Bolster Market's Demand

The increasing efforts of the government of Japan to boost the country's birthrate are augmenting the market's growth by creating an environment that is supportive of improving reproductive health and encourages the general public to focus on family planning. The government's initiatives to support family planning include provision of subsidies for fertility preservation services, financial incentives, and improvement in work-life balance. In December 2024, the Tokyo government announced the 4-day work week for its employees, starting April 2025, to improve the falling fertility rates in the country. The government has also made provision to allow parents of young children to trade their salary to leave work earlier than usual. By enforcing the four-day work week, the government hopes that couples will have reduced work pressure and will be able to focus on raising children and building families. As more couples focus on starting families, the requirement for private and convenient testing solutions is expected to increase significantly in the country, resulting in the rapid growth and expansion of the market.

Increasing Incidences of Gynecological Disorders Boosts Market Expansion

The rising cases of gynecological disorders are propelling the requirement for reproductive health monitoring tools, including fertility and pregnancy rapid kits. Some of the most prevalent gynecological conditions among women include endometriosis, dysmenorrhea, and vulvovaginal symptoms. According to the estimates of an article published in the Journal of Obstetrics and Gynecology Research in May 2024, approximately 80% of women in Japan in their 20s to 50s experience vulvovaginal symptoms. Such disorders can often result in the development of fertility issues, prompting individuals to rely on different tools and technologies to monitor their fertility status and pregnancy. Thus, providing lucrative growth opportunities to the market due to cultural perceptions, most individuals prefer to use convenient and private testing solutions for managing and monitoring their reproductive health.

Pregnancy Rapid Tests Account for Significant Market Share

The segment's growth can be attributed to the widespread use of pregnancy rapid tests due to the convenience offered by these solutions. These devices are affordable, easy to use, and provide quick results, making them increasingly popular among couples in Japan for confirming pregnancies early. The preference for privacy is further propelling the reliance on at-home testing solutions including pregnancy rapid tests in Japan. Moreover, these kits are easily available across a wide range of distribution channels, including e-commerce platforms, supermarkets, and pharmacies, improving their accessibility and providing lucrative opportunities for the segment's expansion.

Future Market Scenario (FY2025 - FY2032F)

According to the Japan fertility and pregnancy rapid kits market analysis, the market is anticipated to observe significant growth in the coming years due to a strong cultural focus on health and wellness, continuous technological innovations, and rising consumer awareness about the different technologies and services available in the market.

Growing emphasis on family planning and increasing popularity of delayed parenthood in the country are also expected to positively influence the market's expansion as fertility tracking becomes crucial for couples planning pregnancies at later stages of life. Moreover, rising government initiatives to support fertility services to combat the declining birthrate are also expected to positively influence the affordability and availability of fertility and pregnancy rapid kits.

Educational campaigns and public health initiatives that promote reproductive health awareness are also expected to propel the market's demand. Growing discussions about pregnancy, fertility, and infertility in online forums and media in the country are normalizing at home testing and monitoring and reducing the stigma associated with these topics.

Key Players Landscape and Outlook

Novel product launches by the leading pregnancy and fertility kit providers is supporting the market's expansion. In October 2024, First Response (Church & Dwight Co., Inc.) launched the Multi Check Pregnancy Test Kit featuring EasyCup. The kit's innovative design simplifies the process of confirming the pregnancy. The EasyCup integrates a sample collection cup with a test strip and draws inspiration from clinical urine sample collection methods. The kit contains two rapid result pregnancy tests and one EasyCup, providing multiple options for conducting tests and enhancing user convenience.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Fertility and Pregnancy Rapid Kits Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Pregnancy Rapid Tests
      • 4.2.1.1.1. Line Indicator
        • 4.2.1.1.1.1. Strips/ Dip Sticks
        • 4.2.1.1.1.2. Mid-stream
        • 4.2.1.1.1.3. Cassettes
      • 4.2.1.1.2. Digital
    • 4.2.1.2. Fertility Rapid Tests
      • 4.2.1.2.1. Line Indicator
      • 4.2.1.2.2. Digital
  • 4.2.2. By Test Type
    • 4.2.2.1. LH Urine
    • 4.2.2.2. FSH Urine
    • 4.2.2.3. hCG Blood
    • 4.2.2.4. hCG Urine
  • 4.2.3. By Distribution Channel
    • 4.2.3.1. Pharmacies
    • 4.2.3.2. Gynecology/Fertility Clinics
    • 4.2.3.3. E-commerce platforms
    • 4.2.3.4. Hypermarkets and Supermarkets
  • 4.2.4. By Region
    • 4.2.4.1. North [Hokkaido and Tohoku]
    • 4.2.4.2. Central [Kanto and Chubu]
    • 4.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Test Type
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Clinical Trials
• 12.2. Regulatory Approvals

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Alere Inc.
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Quidel Corporation
  • 15.3.3. Prestige Brands Holdings, Inc.
  • 15.3.4. Church & Dwight Co., Inc.
  • 15.3.5. bioMerieux SA
  • 15.3.6. Geratherm Medical AG
  • 15.3.7. Abbott Laboratories
  • 15.3.8. Procter & Gamble Co.
  • 15.3.9. DCC Plc.
  • 15.3.10. MIZUHO MEDY Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer